ECSP066440A - Derivados de piperazina inhibidores de quimioquinas y su uso para tratar la miocarditis - Google Patents

Derivados de piperazina inhibidores de quimioquinas y su uso para tratar la miocarditis

Info

Publication number
ECSP066440A
ECSP066440A EC2006006440A ECSP066440A ECSP066440A EC SP066440 A ECSP066440 A EC SP066440A EC 2006006440 A EC2006006440 A EC 2006006440A EC SP066440 A ECSP066440 A EC SP066440A EC SP066440 A ECSP066440 A EC SP066440A
Authority
EC
Ecuador
Prior art keywords
chemiokin
inhibiting
piperazine derivatives
treat myocarditis
myocarditis
Prior art date
Application number
EC2006006440A
Other languages
English (en)
Inventor
Hideki Futamatsu
Mitsuaki Isobe
Noritaka Koga
Jun-Ichi Suzuki
William P Dole
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34216121&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP066440(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of ECSP066440A publication Critical patent/ECSP066440A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se relaciona con derivados de piperazina de las fórmulas Ia, Ib, Ic y Id, y su uso para tratar la miocarditis, donde R1a , R1b, R2 , R3, R4, R5, R6, R9, R10 y Y son tal como se encuentran definidos.
EC2006006440A 2003-08-22 2006-03-20 Derivados de piperazina inhibidores de quimioquinas y su uso para tratar la miocarditis ECSP066440A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49738003P 2003-08-22 2003-08-22

Publications (1)

Publication Number Publication Date
ECSP066440A true ECSP066440A (es) 2006-09-18

Family

ID=34216121

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006440A ECSP066440A (es) 2003-08-22 2006-03-20 Derivados de piperazina inhibidores de quimioquinas y su uso para tratar la miocarditis

Country Status (17)

Country Link
US (2) US20050043318A1 (es)
EP (1) EP1660089A1 (es)
JP (1) JP2007503397A (es)
CN (1) CN1838957A (es)
AR (1) AR046329A1 (es)
AU (1) AU2004266153A1 (es)
BR (1) BRPI0413846A (es)
CA (1) CA2534941A1 (es)
CR (1) CR8286A (es)
EC (1) ECSP066440A (es)
IL (1) IL173584A0 (es)
MX (1) MXPA06002053A (es)
NO (1) NO20061287L (es)
PE (1) PE20050871A1 (es)
RU (1) RU2006108865A (es)
WO (1) WO2005018642A1 (es)
ZA (1) ZA200602306B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005274574B2 (en) * 2004-08-18 2011-03-17 Ace Aps Cosmetic and pharmaceutical compositions comprising ACE inhibitors and/or angiotensin II receptor antagonists
US8097610B2 (en) 2005-08-26 2012-01-17 Shionogi & Co., Ltd. Derivative having PPAR agonistic activity
AP2016009020A0 (en) 2013-07-18 2016-02-29 Novartis Ag Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT634175E (pt) * 1993-07-15 2001-06-29 Hoffmann La Roche Combinacao farmaceutica que contem um inibidor do sistema renina-angiotensina e o antagonista de endotelina
US5631245A (en) * 1995-06-06 1997-05-20 Biodynamics Pharmaceuticals, Inc. Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions
US6207665B1 (en) * 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US20020052420A1 (en) * 1998-12-02 2002-05-02 George Hasko Method and composition for modulating an immune response
AU4796700A (en) * 1999-05-13 2000-12-05 Dupont Pharmaceuticals Research Laboratories, Inc. Ureido-substituted cyclic amine derivatives and their use as drug
ATE277903T1 (de) * 1999-05-14 2004-10-15 Bristol Myers Squibb Pharma Re Zyklische aminderivate und ihre verwendung
JP2001064202A (ja) * 1999-08-25 2001-03-13 Kissei Pharmaceut Co Ltd 心不全予防治療剤
US6740636B2 (en) * 2000-07-31 2004-05-25 Schering Aktiengesellschaft Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection

Also Published As

Publication number Publication date
AR046329A1 (es) 2005-12-07
CA2534941A1 (en) 2005-03-03
NO20061287L (no) 2006-05-18
US20050043318A1 (en) 2005-02-24
JP2007503397A (ja) 2007-02-22
BRPI0413846A (pt) 2006-10-24
IL173584A0 (en) 2006-07-05
EP1660089A1 (en) 2006-05-31
RU2006108865A (ru) 2007-09-27
PE20050871A1 (es) 2005-11-02
AU2004266153A1 (en) 2005-03-03
WO2005018642A1 (en) 2005-03-03
CR8286A (es) 2006-12-07
US20080269247A1 (en) 2008-10-30
MXPA06002053A (es) 2006-08-11
CN1838957A (zh) 2006-09-27
ZA200602306B (en) 2009-08-26

Similar Documents

Publication Publication Date Title
ECSP045255A (es) Cumarinas utiles como biomarcadores
ATE469892T1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
BR0115436A (pt) Compostos de piperazinilpirazina atuando como antagonistas do receptor 5ht-2 de serotonina
CU20070160A7 (es) Pirrolopirazoles, inhibidores potentes de quinasa
CR11492A (es) Peptidil nitrilos y uso de los mismos como inhibidores de dipeptidil peptidasa i
ECSP088558A (es) Carbonilamino pirrolopirazoles, potentes inhibidores de quinasa
GT200600035A (es) Aminopiridinas como inhibidores de beta-secretasa
DE602004017736D1 (de) Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust
UY27427A1 (es) Nuevas dihidro-pteridinonas, procedimientos para su preparación y su utilización como medicamentos
UY28150A1 (es) Agentes terapeuticos
BRPI0413022A (pt) derivados de 3-amino cromado e 2-amino tetralina
TW200700422A (en) Compounds for inhibiting ksp kinesin activity
UY28694A1 (es) Nuevos compuestos
MXPA05010875A (es) Derivados de piperazina como inhibidores de renina.
MXPA05009282A (es) Derivados de anilina sustituidos.
TW200700066A (en) Compounds for inhibiting ksp kinesin activity
DE602004014628D1 (de) Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren
ECSP044971A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson
UA101979C2 (ru) Производные (пиперазинил мостиковый)-1-алканона и их применение как ингибиторов р75
UY29768A1 (es) Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.
ECSP066440A (es) Derivados de piperazina inhibidores de quimioquinas y su uso para tratar la miocarditis
ECSP055965A (es) Oxatiincarboxamidas
EA200600608A1 (ru) Производные имидазопиридина как ингибиторы индуцируемой no-синтазы
SG171472A1 (en) Substituted aniline derivatives